Janssen-cilag Ltd.

This study observes patients with moderate-to-severe psoriasis who are switching from one biologic medication (ustekinumab) to another (guselkumab) in regular clinical practice. Researchers will track 200 patients for one year to see how well the new treatment controls their skin…

This study is testing whether the drug guselkumab can heal all layers of the intestinal wall in people with Crohn's disease. Researchers will use MRI scans and other tests to see if the drug reduces inflammation and promotes healing throughout the digestive tract. The trial invol…

This study is observing how well the drug guselkumab works for adults with moderate-to-severe Crohn's disease or ulcerative colitis in real-world UK clinics. It will track 220 patients to see if the treatment reduces symptoms, improves quality of life, and helps them stop using s…

This study aims to understand how two newer immunotherapy drugs (teclistamab and talquetamab) work for patients with advanced multiple myeloma in real-world medical settings, not in controlled clinical trials. Researchers will look back at the medical records of about 900 patient…